MIRA Pharmaceuticals has completed dosing in its Phase I clinical trial of Ketamir-2, the company’s selective oral N-methyl-D-aspartate (NMDA) receptor modulator, assessing its safety, tolerability, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

BOSTON (WWLP) – The Massachusetts Immigrant and Refugee Advocacy (MIRA) Coalition is joining a lawsuit to defend how the U.S. Census counts residents.

"I miss you Dad!!!" Mira Sorvino wrote about her father Paul Sorvino, who died last month of natural causes at age 83 Mira Sorvino is continuing to mourn the death of her father, Paul Sorvino. In a ...

If you’ve ever considered fertility tracking — also known as ovulation tracking and natural family planning — chances are you’ve come across the Mira Fertility Tracker. Mira is a high-tech at-home ...

Advancing a selective oral NMDA receptor modulator toward Phase 2a in chemotherapy-induced peripheral neuropathy following favorable Phase 1 safety and tolerability findings ...